Back to TWO SIGMA INVESTMENTS, LP TWO SIGMA INVESTMENTS, LP

SCTLSCTL
13 quarters

Position history for TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP's holdings in RECRO PHARMA INC

No. Two Sigma exited its SCTL (Recro Pharma) position in Q2 2024. Its Q1 2024 13F listed 19,500 shares worth $21,060. Two Sigma first reported SCTL in Q2 2019 and held it in 10 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$147,000

Total Shares Change

-14,500

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q2
Latest
Exited
0
-100.0%
$00.0%—
0
2024-Q1
New
19,500
-
$21,0600.0%—
29
2021-Q4
Exited
0
-100.0%
$00.0%—
0
2021-Q3
Increased
110,088
+75.0%
$227,0000.0%—
35
2021-Q2
Increased
62,891
+319.3%
$145,0000.0%—
36
2021-Q1
New
15,000
-
$42,0000.0%—
28
2020-Q4
Exited
0
-100.0%
$00.0%—
0
2020-Q3
Increased
249,235
+18.7%
$523,0000.0%—
28
2020-Q2
Increased
209,963
+20.4%
$955,0000.0%—
30
2020-Q1
Decreased
174,373
-49.5%
$1.4M0.0%—
0
2019-Q4
Increased
345,415
+2231.2%
$6.3M0.0%—
44
2019-Q3
Increased
14,817
+2.2%
$164,0000.0%—
23
2019-Q2
New
14,500
-
$147,0000.0%—
31

Other major holders of SCTL: RENAISSANCE TECHNOLOGIES LLC, PANAGORA ASSET MANAGEMENT INC, MILLENNIUM MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used